These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 17560633)
1. The endogenous thrombin potential and the risk of venous thromboembolism. Tripodi A; Martinelli I; Chantarangkul V; Battaglioli T; Clerici M; Mannucci PM Thromb Res; 2007; 121(3):353-9. PubMed ID: 17560633 [TBL] [Abstract][Full Text] [Related]
2. Thrombin generation as an intermediate phenotype for venous thrombosis. Segers O; van Oerle Rv; ten Cate Ht; Rosing J; Castoldi E Thromb Haemost; 2010 Jan; 103(1):114-22. PubMed ID: 20062924 [TBL] [Abstract][Full Text] [Related]
3. Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia. Wichers IM; Tanck MW; Meijers JC; Lisman T; Reitsma PH; Rosendaal FR; Büller HR; Middeldorp S Thromb Haemost; 2009 Mar; 101(3):465-70. PubMed ID: 19277406 [TBL] [Abstract][Full Text] [Related]
4. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study. Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D; Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158 [TBL] [Abstract][Full Text] [Related]
5. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis. Tripodi A; Primignani M; Lemma L; Chantarangkul V; Mannucci PM J Hepatol; 2013 Aug; 59(2):265-70. PubMed ID: 23583273 [TBL] [Abstract][Full Text] [Related]
6. Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence. van Hylckama Vlieg A; Christiansen SC; Luddington R; Cannegieter SC; Rosendaal FR; Baglin TP Br J Haematol; 2007 Sep; 138(6):769-74. PubMed ID: 17760809 [TBL] [Abstract][Full Text] [Related]
7. Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotype. Dargaud Y; Trzeciak MC; Bordet JC; Ninet J; Negrier C Thromb Haemost; 2006 Nov; 96(5):562-7. PubMed ID: 17080211 [TBL] [Abstract][Full Text] [Related]
8. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years. Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267 [TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity. Strandberg K; Svensson PJ; Ohlin AK Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343 [TBL] [Abstract][Full Text] [Related]
10. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma. Duchemin J; Pan-Petesch B; Arnaud B; Blouch MT; Abgrall JF Thromb Haemost; 2008 Apr; 99(4):767-73. PubMed ID: 18392335 [TBL] [Abstract][Full Text] [Related]
11. Thrombin generation in patients after acute deep-vein thrombosis. ten Cate-Hoek AJ; Dielis AW; Spronk HM; van Oerle R; Hamulyák K; Prins MH; ten Cate H Thromb Haemost; 2008 Aug; 100(2):240-5. PubMed ID: 18690343 [TBL] [Abstract][Full Text] [Related]
12. Increased thrombin generation in inflammatory bowel diseases. Saibeni S; Saladino V; Chantarangkul V; Villa F; Bruno S; Vecchi M; de Franchis R; Sei C; Tripodi A Thromb Res; 2010 Mar; 125(3):278-82. PubMed ID: 19914688 [TBL] [Abstract][Full Text] [Related]
13. Thrombin generation: a comparison of assays using platelet-poor and -rich plasma and whole blood samples from healthy controls and patients with a history of venous thromboembolism. Tappenden KA; Gallimore MJ; Evans G; Mackie IJ; Jones DW Br J Haematol; 2007 Oct; 139(1):106-12. PubMed ID: 17854314 [TBL] [Abstract][Full Text] [Related]
14. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation. Seo JW; Kim HK; Kim JE; Park S; Cho HI Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738 [TBL] [Abstract][Full Text] [Related]
15. Thrombin generation and venous thromboembolism. Eichinger S Hamostaseologie; 2008 Feb; 28(1-2):37-9. PubMed ID: 18278160 [TBL] [Abstract][Full Text] [Related]
16. High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism. Tripodi A; Legnani C; Chantarangkul V; Cosmi B; Palareti G; Mannucci PM J Thromb Haemost; 2008 Aug; 6(8):1327-33. PubMed ID: 18485081 [TBL] [Abstract][Full Text] [Related]
18. Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability. Chantarangkul V; Clerici M; Bressi C; Giesen PL; Tripodi A Haematologica; 2003 May; 88(5):547-54. PubMed ID: 12745274 [TBL] [Abstract][Full Text] [Related]
19. Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V Leiden. Lincz LF; Lonergan A; Scorgie FE; Rowlings P; Gibson R; Lawrie A; Seldon M Pathophysiol Haemost Thromb; 2006; 35(6):435-9. PubMed ID: 17565236 [TBL] [Abstract][Full Text] [Related]
20. Impaired binding of thrombin to thrombomodulin is associated with risk of deep vein thrombosis. Suehisa E; Kawasaki T; Toku M; Hidaka Y Thromb Res; 2008; 123(1):85-92. PubMed ID: 18590927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]